Clinical benefits of tight glycaemic control: effect on the kidney

Best Practice & Research. Clinical Anaesthesiology
Jan Gunst, Miet Schetz

Abstract

Acute kidney injury is a frequent and life-threatening complication of critical illness. Prevention of this condition is crucial. Two randomized single center trials in critically ill patients have shown a decrease in acute kidney injury by tight glycaemic control, an effect that appears most pronounced in surgical patients. Subsequent randomized trials did not confirm this renoprotective effect. This apparent contradiction is likely explained by methodological differences between studies, including different patient populations, insufficient patient numbers, comparison with a different control group, use of inaccurate blood glucose analyzers, and differences in the degree of reaching the target blood glucose level. The optimal glycaemic target for renoprotection in critical illness remains to be defined. Possible mechanisms underlying the renoprotective effect of tight glycaemic control are prevention of glucose overload and toxicity and the associated mitochondrial damage, an anti-inflammatory or anti-apoptotic effect, prevention of endothelial dysfunction, and an improvement of the lipid profile.

References

Jun 1, 1989·The Journal of Surgical Research·R M PodrazikL G D'Alecy
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jan 17, 2002·The New England Journal of Medicine·G van den BergheR Bouillon
Jan 22, 2002·Best Practice & Research. Clinical Endocrinology & Metabolism·B A Mizock
Mar 29, 2002·Kidney International·Jan MelinBengt C Fellström
Apr 3, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·David A AllenMuhammad M Yaqoob
Apr 17, 2003·Current Opinion in Nephrology and Hypertension·M Luiza Caramori, Michael Mauer
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Christoph ThiemermannPrabal K Chatterjee
Oct 23, 2003·JAMA : the Journal of the American Medical Association·UNKNOWN Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Resea
Jan 13, 2004·The Journal of Clinical Endocrinology and Metabolism·Dieter MesottenGreet Van den Berghe
Jul 16, 2004·Kidney International·Joseph V Bonventre, Anna Zuk
Jul 16, 2004·Kidney International·Bruce A Molitoris, Timothy A Sutton
Jul 16, 2004·Kidney International·Gur P KaushalSudhir V Shah
Aug 18, 2004·Critical Care : the Official Journal of the Critical Care Forum·Rinaldo BellomoUNKNOWN Acute Dialysis Quality Initiative workgroup
Nov 3, 2004·The Journal of Clinical Investigation·Greet Van den Berghe
Feb 1, 2005·Lancet·Norbert LameireRaymond Vanholder
Jul 13, 2005·Mayo Clinic Proceedings·Gunjan Y GandhiM Molly McMahon
Jul 22, 2005·Clinical Science·Casper G Schalkwijk, Coen D A Stehouwer
Aug 3, 2005·The Journal of Clinical Investigation·Lies LangoucheGreet Van den Berghe
Feb 3, 2006·The New England Journal of Medicine·Greet Van den BergheRoger Bouillon
Feb 10, 2006·American Journal of Physiology. Renal Physiology·Thangavel SamikkannuThomas J Thekkumkara
Mar 28, 2006·Journal of the American Society of Nephrology : JASN·Paola FiorettoMichele Mussap
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Louis MonnierClaude Colette
May 19, 2006·Journal of the American Society of Nephrology : JASN·Prasad Devarajan
Jan 16, 2007·Chest·Ramesh Venkataraman, John A Kellum
Mar 31, 2007·Seminars in Thoracic and Cardiovascular Surgery·Paresh DandonaPriya Mohanty
May 17, 2007·The American Journal of the Medical Sciences·Liang-Yu LinHong-Da Lin
May 31, 2007·Revista española de cardiología·Lars RydénInga Thrainsdottir
Jul 19, 2007·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Helena W RodbardUNKNOWN AACE Diabetes Mellitus Clinical Practice Guidelines Task Force
Sep 22, 2007·Critical Care Medicine·Mervyn Singer
Nov 27, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Prabal K Chatterjee
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Jan 10, 2008·Diabetes Care·UNKNOWN American Diabetes Association
Jan 11, 2008·The New England Journal of Medicine·Frank M BrunkhorstUNKNOWN German Competence Network Sepsis (SepNet)

❮ Previous
Next ❯

Citations

Dec 15, 2015·BJU International·Peter G Deutsch, Kesavapilla Subramonian
Mar 10, 2012·Journal of Diabetes Science and Technology·Vijay Srinivasan
Jun 3, 2009·Journal of Neurochemistry·David F CummingsJohn A Schetz
Mar 5, 2018·Critical Care : the Official Journal of the Critical Care Forum·Lvlin ChenAndrew Faramand

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.